← Find more feeds

astrazeneca.com

Press releases

Get the latest updates from Press releases directly as they happen.

Follow now 65 followers

Latest posts

Last updated 2 days ago

Lynparza in combination with abiraterone significantly delayed disease progression in all-comers in PROpel Phase III trial in 1st-line metastatic castration-resistant prostate cancer

2 days ago

Read full

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity

3 days ago

Read full

AstraZeneca to invest $360m in advanced manufacturing facility in Ireland

5 days ago

Read full

Imfinzi plus chemotherapy tripled patient survival at three years in the CASPIAN Phase III trial in extensive-stage small cell lung cancer

7 days ago

Read full

Enhertu demonstrated robust and durable tumour response of 54.9% in patients with HER2-mutant metastatic non-small cell lung cancer

8 days ago

Read full

Enhertu reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer

8 days ago

Read full

Imfinzi combined with novel immunotherapies improved clinical outcomes for patients with unresectable, Stage III non-small cell lung cancer

9 days ago

Read full

Enhertu demonstrated clinically meaningful and durable response in patients with HER2-positive advanced gastric cancer in DESTINY-Gastric02 Phase II trial

9 days ago

Read full

Imfinzi and tremelimumab with chemotherapy improved progression-free survival by 28% and overall survival by 23% in 1st-line Stage IV non-small cell lung cancer vs. chemotherapy

16 days ago

Read full

International Respiratory Coalition launches to transform post-pandemic respiratory healthcare

17 days ago

Read full

Fixed-dose combination of albuterol and budesonide (PT027) demonstrated significant benefits for asthma patients in MANDALA and DENALI Phase III trials

17 days ago

Read full

AstraZeneca and European Commission reach settlement agreement over vaccine supply, ending litigation

23 days ago

Read full

Or log in

Everything you care about in one place

Press releases

Latest posts

Lynparza in combination with abiraterone significantly delayed disease progression in all-comers in PROpel Phase III trial in 1st-line metastatic castration-resistant prostate cancer

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity

AstraZeneca to invest $360m in advanced manufacturing facility in Ireland

Imfinzi plus chemotherapy tripled patient survival at three years in the CASPIAN Phase III trial in extensive-stage small cell lung cancer

Enhertu demonstrated robust and durable tumour response of 54.9% in patients with HER2-mutant metastatic non-small cell lung cancer

Enhertu reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer

Imfinzi combined with novel immunotherapies improved clinical outcomes for patients with unresectable, Stage III non-small cell lung cancer

Enhertu demonstrated clinically meaningful and durable response in patients with HER2-positive advanced gastric cancer in DESTINY-Gastric02 Phase II trial

Imfinzi and tremelimumab with chemotherapy improved progression-free survival by 28% and overall survival by 23% in 1st-line Stage IV non-small cell lung cancer vs. chemotherapy

International Respiratory Coalition launches to transform post-pandemic respiratory healthcare

Fixed-dose combination of albuterol and budesonide (PT027) demonstrated significant benefits for asthma patients in MANDALA and DENALI Phase III trials

AstraZeneca and European Commission reach settlement agreement over vaccine supply, ending litigation

Try Feeder for free